Long Term Administration of Endothelin Receptor Antagonist Improves Coronary Endothelial Function in Patients with Early Atherosclerosis

BACKGROUND: Endothelin (ET-1) is one of the most potent vasoconstrictors, and plays a seminal role in the pathogenesis of atherosclerosis. The current study was designed to test the hypothesis that long term treatment with an endothelin-A (ET(A)) receptor antagonist improves coronary endothelial fun...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Reriani, Martin, Raichlin, Eugenia, Prasad, Abhiram, Mathew, Verghese, Pumper, Geralyn M., Nelson, Rebecca E., Lennon, Ryan, Rihal, Charanjit, Lerman, Lilach O., Lerman, Amir
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2946239/
https://ncbi.nlm.nih.gov/pubmed/20733096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.110.967406
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares